Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 26;9(6):3791–3803. doi: 10.1002/ehf2.14050

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Kaplan–Meier curves of clinical outcomes for the primary composite endpoint and its components in patients with baseline NT‐proBNP levels in Quartiles 1–3 (Q1–Q3) and Quartile 4 (Q4). Primary outcome was composite of death from cardiovascular causes or first hospitalization for HF. Cumulative incidences of composite endpoint by NT‐proBNP group (Q1–Q3 and Q4) are shown in Panels A and B, respectively. Cumulative incidences of cardiovascular death by NT‐proBNP group (Q1–Q3 and Q4) are shown in Panels C and D, respectively. Cumulative incidences of first hospitalization by NT‐proBNP group (Q1–Q3 and Q4) are shown in Panels E and F, respectively. CI, confidence interval; CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide.